Substantially pure interleukin-9 receptor and uses thereof
US5116951A · kind A · utility
19Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 1990 |
| Grant date | May 26, 1992 |
| Priority date | — |
| Expiry date | Sep 19, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substantially pure interleukin 9 receptor molecules and the use thereof. The uses include use as an interleukin-9 inhibitor, as a diagnostic agent for determining interleukin-9, and as a screening agent for pharmaceuticals. The interleukin-9 receptor is characterized as a glycoprotein of about 94 kilodaltons which, upon digestion with N-glycosidase F, yields a peptide of about 54 kilodaltons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.